Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab Vedotin
Clinical trial NCT03440788 · UNKNOWN
Trial details
- NCT number
- NCT03440788
- Sponsor
- Multinational Center for Quality of Life Research, Russia
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-04-02
- Primary completion
- 2020-05-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.